why choose us

First received: October 24, 2022

Clinical Trial: Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Osteonecrosis Due to Drugs, Jaw

Study Type: Interventional


Official Title: Benefit of Cryopreserved Human Amniotic Membrane (hAM) on Oral Mucosal Healing Among Patients With Stage II Maxillomandibular Osteonecrosis Induced by Antiresorptive and/or Anti-angiogenic Therapies:

Brief Summary: This study aims to demonstrate, during the first standard surgical management of patients with stage II MRONJ, the effect of the implantation of a cryopreserved hAM on the maxillomandibular bone, on the healing of the oral mucosa.

Read more